BASF Completes Acquisition of DOMO Chemicals' Shares in Alsachimie JV

BASF has acquired DOMO Chemicals' 49% stake in the Alsachimie joint venture and is now the sole owner of the production company for essential precursors of polyamide (PA) 6.6, including KA oil, adipic acid and hexamethylenediamine adipate (AH salt) in Chalampé, France. The parties have agreed not to disclose financial details of the transaction.

With the full acquisition of Alsachimie, BASF strengthens its operational presence at the Chalampé site - the European center for PA 6.6 production. The strategic decision enables BASF to optimize the backward integration of key raw materials and thus ensure a reliable and efficient supply along the PA 6.6 value chain. For DOMO Chemicals, the transaction is in line with its strategy to continue to focus on customized polyamide solutions for core segments such as the automotive, consumer goods, industrial goods and electrical and electronics industries.

The transaction complements a number of strategic measures taken by BASF to further strengthen PA 6.6 production at the Chalampé site, including the newly opened state-of-the-art hexamethylenediamine (HMD) plant and the expansion of PA 6.6 polymerization capacity at the nearby site in Freiburg, Germany.

Location in Chalampé, France
Location in Chalampé, France
© BASF

Company

Logo:

BASF SE

Carl-Bosch-Straße 38
67056 Ludwigshafen
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.